Inactive Instrument

All News Viralytics Ltd.

Equities

VLA

AU000000VLA6

All News

Unlock all the news: Be the first to know and act before the market!

Amgen : Merck to buy virus-based cancer drug firm Viralytics for $394 million	21/02/18	RE
Viralytics : Chairman’s letter to shareholders	28/11/17	PU
Viralytics : New Data Presented at SITC Annual Meeting	12/11/17	PU
Viralytics : Annual Report and Full Year Financial Results	18/08/17	PU
Viralytics : Newsletter	28/06/17	PU
Viralytics : Positive Bio-Marker Data from CANON Study	28/06/17	PU
Viralytics : Update on MITCI and KEYNOTE 200 trials at ASCO Ann Meeting	06/06/17	PU
Viralytics : Progress in the CAVATAK® and KEYTRUDA® Combination KEYNOTE-200 clinical trial	05/04/17	PU
Viralytics : CAVATAK® in Combination with YERVOY® Provides Promising Results in Advanced Melanoma from the Phase 1b MITCI clinical study	05/04/17	PU
Viralytics : Promising Results in CAPRA Trial of CAVATAK® in Combination with KEYTRUDA® in Melanoma Patients	04/04/17	PU
Viralytics : Edison Report – Cavatak combo data at AACR next month	09/03/17	PU
Viralytics : ASX Release – Viralytics to Present New CAVATAK Clinical Data at American Association for Cancer Research Annual Meeting 2017	01/03/17	PU
Viralytics : Receives $4.3 Million R&D Tax Incentive	16/02/17	PU
Viralytics : Promising Advanced Melanoma Results from KEYTRUDA Combination Trial announced at SITC	14/11/16	PU
Viralytics : Dr Malcolm McColl on ABC TV's The Business	06/06/16	PU
Edison: Eye-catching MITCI Data	10/05/16	PU
Viralytics : Further Promising Data at AACR Meeting	21/04/16	PU
Viralytics : Clinical Results at Two Major Conferences	17/03/16	PU
Viralytics : Bioshares Top Six Stock Picks for 2016	21/12/15	PU
Viralytics : Completes $28 million Placement – SPP to Followm	16/12/15	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Viralytics Ltd.

Equities

VLA

AU000000VLA6

All News

Filters